Mein Aufgabenbereich beinhaltet Lehre im Pharmazie-Studium der FU Berlin. Im Einzelnen sind hier Lehrveranstaltungen des 3. Semesters (Arzneiformenlehre) und des 7. Semesters (Pharmazeutische Technologie) zu nennen. Des Weiteren unterliegt mir die Organisation des Arzneiformenlehre-Praktikums.

1) Staufenbiel, S., Keck, C. M., & Müller, R. H. (2014). The real environment quantification of surface hydrophobicity of differently stabilized nanocrystals as key parameter for organ distribution. Macromolecular Symposia, 345(1), 32-41.

2) Staufenbiel, S., Weise, C., & Müller, R. H. (2014). Targeting of intravenous polymeric nanoparticles by differential protein adsorption. Macromolecular Symposia, 345(1), 42-50.

3) Staufenbiel, S., Merino, M., Li, W., Huang, M. D., Baudis, S., Lendlein, A., Müller, R. H., & Wischke, C. (2015). Surface characterization and protein interaction of a series of model poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanocarriers for drug targeting. International Journal of Pharmaceutics, 485(1-2), 87-96.

4) Balzus, B., Colombo, M., Sahle, F. F., Zoubari, G., Staufenbiel, S., & Bodmeier, R. (2016). Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. International Journal of Pharmaceutics, 513(1-2), 247-254.

5) Colombo, M., Staufenbiel, S., Rühl, E., & Bodmeier, R. (2017). In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application. International Journal of Pharmaceutics, 521(1-2), 156-166.

6) Colombo, M., Orthmann, S., Bellini, M., Staufenbiel, S., & Bodmeier, R. (2017). Influence of Drug Brittleness, Nanomilling Time, and Freeze-Drying on the Crystallinity of Poorly Water-Soluble Drugs and Its Implications for Solubility Enhancement. AAPS PharmSciTech, 18(7).

7) Deng, J., Staufenbiel, S., Hao, S., Wang, B., Dashevskiy, A., & Bodmeier, R. (2017). Development of a discriminative biphasic in vitro dissolution test and correlation with in vivo pharmacokinetic studies for differently formulated racecadotril granules. Journal of Controlled Release, 255, 202-209.

8) Deng, J., Staufenbiel, S., & Bodmeier, R. (2017). Evaluation of a biphasic in vitro dissolution test for estimating the bioavailability of carbamazepine polymorphic forms. European Journal of Pharmaceutical Sciences, 105, 64-70.

9) Zoubari, G., Staufenbiel, S., Volz, P., Alexiev, U., & Bodmeier, R. (2017). Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery. European Journal of Pharmaceutics and Biopharmaceutics, 110, 39-46.

10) Colombo, M., Minussi, C., Orthmann, S., Staufenbiel, S., & Bodmeier, R. (2018). Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility. European Journal of Pharmaceutics and Biopharmaceutics, 125, 159-168.

11) Jager, J., Obst, K., Lohan, S. B., Viktorov, J., Staufenbiel, S., Renz, H., Unbehauen, M., Haag, R., Hedtrich, S., Teutloff, C., Meinke, M. C., Danker, K., & Dommisch, H. (2018). Characterization of hyperbranched core-multishell nanocarriers as an innovative drug delivery system for the application at the oral mucosa. Journal of Periodontal Research, 53(1).

12) Lohan, S. B., Saeidpour, S., Colombo, M., Staufenbiel, S., Unbehauen, M., Wolde‐Kidan, A., Netz, R. R., Bodmeier, R., Haag, R., Teutloff, C., Bittl, R., & Meinke, M. C. (2020). Nanocrystals for improved drug delivery of dexamethasone in skin investigated by EPR spectroscopy. Pharmaceutics, 12(5).

13) Ali, R., & Staufenbiel, S. (2021). Preparation and characterization of dexamethasone lipid nanoparticles by membrane emulsification technique, use of self-emulsifying lipids as a carrier and stabilizer. Pharmaceutical Development and Technology, 26(3), 262-268.

14) Sinha, B., Staufenbiel, S., Müller, R. H., & Möschwitzer, J. P. (2021). Sub-50 nm ultra-small organic drug nanosuspension prepared by cavi-precipitation and its brain targeting potential. International Journal of Pharmaceutics, 607.

15) Huang, Z., Staufenbiel, S., & Bodmeier, R. (2022). Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs. Pharmaceutical Research, 39(5).

16) Huang, Z., Staufenbiel, S., & Bodmeier, R. (2022). Kinetic solubility improvement and influence of polymers on controlled supersaturation of itraconazole-succinic acid nano-co-crystals. International Journal of Pharmaceutics, 616.

17) Huang, Z., Staufenbiel, S., & Bodmeier, R. (2022). Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms. European Journal of Pharmaceutics and Biopharmaceutics, 176, 75-86

18) Bach, F., Staufenbiel, S., & Bodmeier, R. (2023). Implications of changes in physical state of drugs in poly(lactide-co-glycolide) matrices upon exposure to moisture and release medium. Journal of Drug Delivery Science and Technology, 80.

19) Yapto, C. V., Rajes, K., Inselmann, A., Staufenbiel, S., Stolte, K. N., Witt, M., Haag, R., Dommisch, H., & Danker, K. (2024). Topical Application of Dexamethasone-Loaded Core-Multishell Nanocarriers Against Oral Mucosal Inflammation. Macromolecular Bioscience, 24(12).

20) Wang, T., & Staufenbiel, S. (2024). Preparation and characterization of stabilizer-free oily nanosuspensions. Journal of Drug Delivery Science and Technology, 92.